Key result
Tp-e interval ≥86 ms and Tp-e/QT ratio ≥0.24 identified malignant arrhythmias triggered by VPCs with sensitivities of 88% and 82%, and specificities of 66% and 70%, respectively.
Why the study?
The study was conducted to evaluate whether the Tp-e interval and (Tp-e)/QT ratio can differentiate benign VPC from malignant PVT.
Do Tp-e interval and (Tp-e)/QT ratio differentiate malignant polymorphic ventricular tachycardia from benign ventricular premature complexes?
Case-Control
Do Tp-e interval and (Tp-e)/QT ratio differentiate malignant polymorphic ventricular tachycardia from benign ventricular premature complexes?
Tp-e interval and the Tp-e/QT ratio are significantly increased in patients with PVT/VF and may serve as novel non-invasive markers to differentiate malignant from benign VPCs.
Answers are grounded in this paper and cite their sources.
May aid differentiation of malignant from benign VPCs; leaves open prospective validation before clinical adoption.
BACKGROUND: To evaluate the role of Tp-e and (Tp-e)/QT ratio in differentiating benign ventricular premature complex (VPC) and malignant polymorphic ventricular tachycardia (PVT). METHODS: From January 2017 to December 2017, patients with documented polymorphic ventricular tachycardia (PVT) or ventricular fibrillation (VF) were consecutive included and classified as PVT/VF group. Sixty age- and sex-matched healthy individuals were recruited as comparative control and subdivided into non-VPC and VPC group. Clinical characteristics and Tp-e and Tp-e/QT ratio between the three groups were compared. RESULTS: Tp-e and (Tp-e)/QT ratio were significantly higher in patients of PVT/VF group compared with the other two groups (P < .001). Episodes of syncope were more frequent in patients with PVT/VF (P < .05). The sensitivity and specificity of a Tp-e interval ≥86 ms for malignant arrhythmias triggered by VPCs were 88% and 66%, respectively, while the sensitivity and specificity of the Tp-e/QT ratio ≥0.24 were 82% and 70%, respectively. Five patients complained recurrence of syncope in the PVT/VF group and 1 patient died with mean follow-up of 18 months. CONCLUSION: Tp-e interval and the Tp-Te/QT ratio is significantly increased in patients with PVT/VF and may be used as a novel non-invasive marker of differentiating malignant and benign VPC.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) conducted a case-control in Idiopathic ventricular premature complexes and malignant ventricular arrhythmia. Tp-e interval and (Tp-e)/QT ratio vs. Healthy individuals with and without benign VPCs was evaluated on Differentiation of malignant PVT/VF from benign VPCs using Tp-e and (Tp-e)/QT ratio (p=<.001). Tp-e interval ≥86 ms and Tp-e/QT ratio ≥0.24 identified malignant arrhythmias triggered by VPCs with sensitivities of 88% and 82%, and specificities of 66% and 70%, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: